Pasquali Sara K, Cohen Meryl S, Shera David, Wernovsky Gil, Spray Thomas L, Marino Bradley S
Division of Cardiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
J Am Coll Cardiol. 2007 May 1;49(17):1806-12. doi: 10.1016/j.jacc.2007.01.071. Epub 2007 Apr 16.
The purpose of this study was to describe the relationship between neo-aortic root size, neo-aortic insufficiency (AI), and reintervention at mid-term follow-up.
Data on neo-aortic valve function and growth after the Ross procedure in children are limited.
A total of 74 of 119 Ross patients from January 1995 to December 2003 had > or =2 follow-up echocardiograms at our institution and were included. Neo-aortic dimensions were converted to z-scores and modeled over time. Kaplan-Meier analysis was used to assess freedom from neo-aortic outcomes, and predictors were identified through multivariate analysis.
Median age at Ross was 9 years (range 3 days to 34 years). Over 4.7 years (range 3 months to 9.3 years) follow-up, there was disproportionate enlargement of the neo-aortic root (z-score increase of 0.75/year [p < 0.0001]). Neo-AI progressed > or =1 grade in 36% of patients and > or =2 grades in 15%. Nine patients (12%) had neo-aortic reintervention at 2.0 years (range 1.1 to 9.5 years) after the Ross procedure owing to severe neo-AI (n = 7), neo-aortic root dilation (n = 1), and neo-aortic pseudoaneurysm (n = 1). At 6 years after the Ross procedure, freedom from neo-aortic reintervention was 88%. Freedom from neo-aortic root z-score >4 was only 3% and from moderate or greater neo-AI was 60%. Longer follow-up time was associated with neo-aortic root dilation (p < 0.0001). Prior ventricular septal defect (VSD) repair predicted neo-AI (p = 0.02) and reintervention (p = 0.03). Prior aortic valve replacement (p = 0.002) also predicted neo-AI. Neo-aortic root dilation was not associated with neo-AI or reintervention.
At mid-term follow-up after the Ross procedure, neo-aortic root size increases significantly out of proportion to somatic growth, and neo-AI is progressive. Prior VSD repair and aortic valve replacement were associated with neo-AI and reintervention.
本研究旨在描述中期随访时新主动脉根部大小、新主动脉瓣关闭不全(AI)与再次干预之间的关系。
儿童Ross手术后新主动脉瓣功能和生长的数据有限。
1995年1月至2003年12月期间,119例Ross手术患者中有74例在我们机构进行了≥2次随访超声心动图检查,并纳入研究。将新主动脉尺寸转换为z评分并随时间建模。采用Kaplan-Meier分析评估新主动脉结局的无事件生存率,并通过多变量分析确定预测因素。
Ross手术时的中位年龄为9岁(范围3天至34岁)。在4.7年(范围3个月至9.3年)的随访中,新主动脉根部不成比例地增大(z评分每年增加0.75 [p < 0.0001])。36%的患者新AI进展≥1级,15%的患者进展≥2级。9例患者(12%)在Ross手术后2.0年(范围1.1至9.5年)因严重新AI(n = 7)、新主动脉根部扩张(n = 1)和新主动脉假性动脉瘤(n = 1)进行了新主动脉再次干预。Ross手术后6年,新主动脉再次干预的无事件生存率为88%。新主动脉根部z评分>4的无事件生存率仅为3%,中度或更严重新AI的无事件生存率为60%。随访时间延长与新主动脉根部扩张相关(p < 0.0001)。既往室间隔缺损(VSD)修复可预测新AI(p = 0.02)和再次干预(p = 0.03)。既往主动脉瓣置换(p = 0.002)也可预测新AI。新主动脉根部扩张与新AI或再次干预无关。
Ross手术后中期随访时,新主动脉根部大小的增加明显超过身体生长比例,且新AI呈进行性发展。既往VSD修复和主动脉瓣置换与新AI及再次干预有关。